Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Cardiomyopathies D009202 10 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenoma D000236 40 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Vascular Diseases D014652 16 associated lipids
Ovarian Diseases D010049 5 associated lipids
Anemia D000740 21 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Wetter JA et al. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation. 2009 J Biomol Screen pmid:19726785
Li C et al. Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. 2009 Am. J. Pathol. pmid:19729475
Hait NC et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. 2009 Science pmid:19729656
De Luca T et al. Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol. 2008 Biofactors pmid:19734127
Park SW et al. Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. 2010 Shock pmid:19752779
Zhao J et al. Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: role in barrier enhancement. 2009 Cell. Signal. pmid:19755153
Xu Y et al. Lipid generation and signaling in ovarian cancer. 2009 Cancer Treat. Res. pmid:19763440
Wang F and Fishman DA Lysophosphatidic acid and invasion. 2009 Cancer Treat. Res. pmid:19763441
Mochizuki N [Discovery of S1P transporter may uncover the unidentified S1P-regulated signal in circulation, immunity, and bone metabolism]. 2009 Tanpakushitsu Kakusan Koso pmid:19764473
Brakch N et al. Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease. 2010 Eur. Heart J. pmid:19773225
Crousillac S et al. Sphingosine-1-phosphate elicits receptor-dependent calcium signaling in retinal amacrine cells. 2009 J. Neurophysiol. pmid:19776367
Long DA and Price KL Sphingosine kinase-1: a potential mediator of renal fibrosis. 2009 Kidney Int. pmid:19789541
Rhee S et al. Promigratory and procontractile growth factor environments differentially regulate cell morphogenesis. 2010 Exp. Cell Res. pmid:19796636
Hla T Plugging vascular leak by sphingosine kinase from bone marrow progenitor cells. 2009 Circ. Res. pmid:19797192
Abrahan CE et al. Synthesis of sphingosine is essential for oxidative stress-induced apoptosis of photoreceptors. 2010 Invest. Ophthalmol. Vis. Sci. pmid:19797232
Gratschev D et al. Sphingosine kinase as a regulator of calcium entry through autocrine sphingosine 1-phosphate signaling in thyroid FRTL-5 cells. 2009 Endocrinology pmid:19797403
Xiang Y et al. Discovery of novel sphingosine kinase 1 inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19800228
Tachikawa M et al. Lysophospholipids enhance taurine release from rat retinal vascular endothelial cells under hypoosmotic stress. 2009 Microvasc. Res. pmid:19804786
Coelho RP et al. Sphingosine-1-phosphate and oligodendrocytes: from cell development to the treatment of multiple sclerosis. 2010 Prostaglandins Other Lipid Mediat. pmid:19808013
Jenne CN et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. 2009 J. Exp. Med. pmid:19808259
Brinkmann V FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. 2009 Br. J. Pharmacol. pmid:19814729
Wojciak JM et al. The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19815502
Morris AJ et al. Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation. 2009 Trends Cardiovasc. Med. pmid:19818950
Jacobson JR Pharmacologic therapies on the horizon for acute lung injury/acute respiratory distress syndrome. 2009 J. Investig. Med. pmid:19820408
Rolin J et al. FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release. 2010 Cancer Immunol. Immunother. pmid:19823820
Mochizuki N Vascular integrity mediated by vascular endothelial cadherin and regulated by sphingosine 1-phosphate and angiopoietin-1. 2009 Circ. J. pmid:19838001
Malchinkhuu E et al. Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cells. 2009 Mol. Biol. Cell pmid:19864456
Heo K et al. Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. 2009 BMB Rep pmid:19874715
Greco E et al. Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells. 2010 Immunology pmid:19878354
Haghikia A and Gold R Sphingosine-1-phosphate and its receptors as a possible therapeutic target in autoimmune diseases of the nervous system. 2010 J. Neuroimmunol. pmid:19879005
Espinosa Cervantes R [Sphingolipids in embryonic implantation]. 2009 Ginecol Obstet Mex pmid:19899433
Hancke K et al. Ovarian transplantation for fertility preservation in a sheep model: can follicle loss be prevented by antiapoptotic sphingosine-1-phosphate administration? 2009 Gynecol. Endocrinol. pmid:19906004
Claas RF et al. Enhanced Ca2+ storage in sphingosine-1-phosphate lyase-deficient fibroblasts. 2010 Cell. Signal. pmid:19913094
Serra M and Saba JD Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. 2010 Adv. Enzyme Regul. pmid:19914275
Chen JH et al. Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival. 2010 J. Lipid Res. pmid:19965613
Diab KJ et al. Stimulation of sphingosine 1-phosphate signaling as an alveolar cell survival strategy in emphysema. 2010 Am. J. Respir. Crit. Care Med. pmid:19965812
Yamamoto Y et al. Increased expression of enzymes for sphingosine 1-phosphate turnover and signaling in human decidua during late pregnancy. 2010 Biol. Reprod. pmid:20007411
Wang S et al. A polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heart. 2010 Glycobiology pmid:20008963
McDonald RA et al. The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia. 2010 Br. J. Pharmacol. pmid:20015089
Pham TH et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. 2010 J. Exp. Med. pmid:20026661
Nayak D et al. Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. 2010 Neuroscience pmid:20036321
Ling B et al. Sphingosine-1-phosphate: a potential therapeutic agent against human breast cancer. 2011 Invest New Drugs pmid:20041340
Danieli-Betto D et al. Sphingosine 1-phosphate signaling is involved in skeletal muscle regeneration. 2010 Am. J. Physiol., Cell Physiol. pmid:20042733
Agudo-López A et al. Involvement of mitochondria on neuroprotective effect of sphingosine-1-phosphate in cell death in an in vitro model of brain ischemia. 2010 Neurosci. Lett. pmid:20045720
Riccio A New endogenous regulators of class I histone deacetylases. 2010 Sci Signal pmid:20051592
Brown M et al. Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endothelium. 2010 Microvasc. Res. pmid:20053363
Tao R et al. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. 2010 Am. J. Physiol. Heart Circ. Physiol. pmid:20061542
Nam JH et al. Ca2+ signaling induced by sphingosine 1-phosphate and lysophosphatidic acid in mouse B cells. 2010 Mol. Cells pmid:20069383
Fletcher JI et al. ABC transporters in cancer: more than just drug efflux pumps. 2010 Nat. Rev. Cancer pmid:20075923
Egom EE et al. Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling. 2010 Prog. Biophys. Mol. Biol. pmid:20080123
Shea BS et al. Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. 2010 Am. J. Respir. Cell Mol. Biol. pmid:20081052
Hannoun A et al. Addition of sphingosine-1-phosphate to human oocyte culture medium decreases embryo fragmentation. 2010 Reprod. Biomed. Online pmid:20093086
Murakami A et al. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. 2010 Mol. Pharmacol. pmid:20097776
Bektas M et al. Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. 2010 J. Biol. Chem. pmid:20097939
Incorvaia C et al. Anaphylaxis: an update on its understanding and management. 2010 Recent Pat Inflamm Allergy Drug Discov pmid:20100165
Dunlap KA et al. The sphingosine 1-phosphate (S1P) signaling pathway is regulated during pregnancy in sheep. 2010 Biol. Reprod. pmid:20107206
Takabe K et al. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. 2010 J. Biol. Chem. pmid:20110355
Aydin M et al. The sphingosine-1-phosphate pathway is upregulated in response to partial urethral obstruction in male rats and activates RhoA/Rho-kinase signalling. 2010 BJU Int. pmid:20128782
Leong WI and Saba JD S1P metabolism in cancer and other pathological conditions. 2010 Biochimie pmid:20167244
Pereira JP et al. A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow. 2010 PLoS ONE pmid:20174580
Yu XQ et al. Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate. 2010 Xenobiotica pmid:20175664
Bode C et al. Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. 2010 J. Cell. Biochem. pmid:20186882
Okae H and Iwakura Y Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. 2010 Dev. Dyn. pmid:20186915
Ikeda H et al. Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C. 2010 Clin. Chim. Acta pmid:20188085
Ma B et al. Stereochemistry-activity relationship of orally active tetralin S1P agonist prodrugs. 2010 Bioorg. Med. Chem. Lett. pmid:20188554
Gangoiti P et al. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease. 2010 Prog. Lipid Res. pmid:20193711
Tölle M et al. Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins. 2010 Curr. Pharm. Des. pmid:20196741
Weigert A et al. Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. 2010 Blood pmid:20197547
Vessey DA et al. Pannexin-I/P2X 7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning. 2010 J. Cardiovasc. Pharmacol. Ther. pmid:20200324
Lee H et al. Bone marrow-derived mesenchymal stem cells prevent the loss of Niemann-Pick type C mouse Purkinje neurons by correcting sphingolipid metabolism and increasing sphingosine-1-phosphate. 2010 Stem Cells pmid:20201063
Qi X et al. Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice. 2010 Eur. J. Pharmacol. pmid:20206620
Xu R et al. Role of alkaline ceramidases in the generation of sphingosine and its phosphate in erythrocytes. 2010 FASEB J. pmid:20207939
Morishige J et al. A clean-up technology for the simultaneous determination of lysophosphatidic acid and sphingosine-1-phosphate by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using a phosphate-capture molecule, Phos-tag. 2010 Rapid Commun. Mass Spectrom. pmid:20213695
Qin J et al. Neurons and oligodendrocytes recycle sphingosine 1-phosphate to ceramide: significance for apoptosis and multiple sclerosis. 2010 J. Biol. Chem. pmid:20215115
Sensken SC et al. Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia. 2010 J. Immunol. pmid:20220090
Kim M et al. Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation. 2010 Am. J. Nephrol. pmid:20234131
Suhaiman L et al. Sphingosine 1-phosphate and sphingosine kinase are involved in a novel signaling pathway leading to acrosomal exocytosis. 2010 J. Biol. Chem. pmid:20236935
Martin R Multiple sclerosis: closing in on an oral treatment. 2010 Nature pmid:20237554
Di A et al. A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury. 2010 J. Biol. Chem. pmid:20299461
Cuvillier O et al. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. 2010 Curr Mol Pharmacol pmid:20302564
Evindar G et al. Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonists. 2010 Bioorg. Med. Chem. Lett. pmid:20304639
Malemud CJ The discovery of novel experimental therapies for inflammatory arthritis. 2009 Mediators Inflamm. pmid:20339519
Lan T et al. Determination of sphingosine kinase activity in biological samples by liquid chromatography-tandem mass spectrometry. 2010 Biomed. Chromatogr. pmid:20352614
Ratajczak MZ et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. 2010 Leukemia pmid:20357827
Alford SK et al. Prediction of sphingosine 1-phosphate-stimulated endothelial cell migration rates using biochemical measurements. 2010 Ann Biomed Eng pmid:20358290
Förster A et al. Glucocorticoids protect renal mesangial cells from apoptosis by increasing cellular sphingosine-1-phosphate. 2010 Kidney Int. pmid:20375982
Sun HY et al. Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis. 2010 Biochem. Biophys. Res. Commun. pmid:20382120
Siow DL et al. Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate. 2010 J. Lipid Res. pmid:20386061
Hu WM et al. Effect of S1P5 on proliferation and migration of human esophageal cancer cells. 2010 World J. Gastroenterol. pmid:20397263
Harvey KA et al. Role of Rho kinase in sphingosine 1-phosphate-mediated endothelial and smooth muscle cell migration and differentiation. 2010 Mol. Cell. Biochem. pmid:20401628
Tawa H et al. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis. 2010 Circ. Res. pmid:20413783
Hoofnagle AN et al. HDL lipids and insulin resistance. 2010 Curr. Diab. Rep. pmid:20425071
Yoshida T et al. Therapeutic angiogenesis by implantation of a capillary structure constituted of human adipose tissue microvascular endothelial cells. 2010 Arterioscler. Thromb. Vasc. Biol. pmid:20431071
Shayman JA The riddle of the sphinx redux. 2010 Kidney Int. pmid:20431574
Kułakowska A et al. Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. 2010 Neurosci. Lett. pmid:20434523
Szczepaniak WS et al. S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. 2010 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:20435688
Bolli MH et al. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists. 2010 J. Med. Chem. pmid:20446681
Norman E et al. Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms. 2010 J. Neurochem. pmid:20456020
Cao C et al. The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. 2010 J. Clin. Invest. pmid:20458145
Park SW et al. Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. 2010 Lab. Invest. pmid:20458275